JP2014533702A - 改良された相乗作用抗糖尿病組成物 - Google Patents

改良された相乗作用抗糖尿病組成物 Download PDF

Info

Publication number
JP2014533702A
JP2014533702A JP2014542643A JP2014542643A JP2014533702A JP 2014533702 A JP2014533702 A JP 2014533702A JP 2014542643 A JP2014542643 A JP 2014542643A JP 2014542643 A JP2014542643 A JP 2014542643A JP 2014533702 A JP2014533702 A JP 2014533702A
Authority
JP
Japan
Prior art keywords
inulin
sulfonylurea
polymerization
degree
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014542643A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533702A5 (enExample
Inventor
ニック ナセル ゴルガーニ
ニック ナセル ゴルガーニ
Original Assignee
オージースター セラピューティクス プロプライアタリ リミテッド
オージースター セラピューティクス プロプライアタリ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011904887A external-priority patent/AU2011904887A0/en
Application filed by オージースター セラピューティクス プロプライアタリ リミテッド, オージースター セラピューティクス プロプライアタリ リミテッド filed Critical オージースター セラピューティクス プロプライアタリ リミテッド
Publication of JP2014533702A publication Critical patent/JP2014533702A/ja
Publication of JP2014533702A5 publication Critical patent/JP2014533702A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2014542643A 2011-11-23 2012-11-23 改良された相乗作用抗糖尿病組成物 Pending JP2014533702A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2011904887A AU2011904887A0 (en) 2011-11-23 Improved synergistic anti-diabetic compositions
AU2011904887 2011-11-23
AU2012902723 2012-06-27
AU2012902723A AU2012902723A0 (en) 2012-06-27 Improved synergistic anti-diabetic compositions -II
PCT/AU2012/001442 WO2013075172A1 (en) 2011-11-23 2012-11-23 Improved synergistic anti-diabetic compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017133685A Division JP6609287B2 (ja) 2011-11-23 2017-07-07 改良された相乗作用を示す抗糖尿病、抗高血糖症又は抗副作用のための医薬組成物及び製剤

Publications (2)

Publication Number Publication Date
JP2014533702A true JP2014533702A (ja) 2014-12-15
JP2014533702A5 JP2014533702A5 (enExample) 2016-01-21

Family

ID=48468910

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014542643A Pending JP2014533702A (ja) 2011-11-23 2012-11-23 改良された相乗作用抗糖尿病組成物
JP2017133685A Active JP6609287B2 (ja) 2011-11-23 2017-07-07 改良された相乗作用を示す抗糖尿病、抗高血糖症又は抗副作用のための医薬組成物及び製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017133685A Active JP6609287B2 (ja) 2011-11-23 2017-07-07 改良された相乗作用を示す抗糖尿病、抗高血糖症又は抗副作用のための医薬組成物及び製剤

Country Status (11)

Country Link
US (1) US9737559B2 (enExample)
EP (1) EP2782586A4 (enExample)
JP (2) JP2014533702A (enExample)
KR (1) KR102104384B1 (enExample)
CN (1) CN104244958B (enExample)
AU (1) AU2012343332B2 (enExample)
BR (1) BR112014012401A2 (enExample)
CA (1) CA2861661C (enExample)
IN (1) IN2014KN01304A (enExample)
RU (1) RU2642633C2 (enExample)
WO (1) WO2013075172A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109498611B (zh) * 2019-01-15 2020-09-01 张惊宇 一种治疗糖尿病周围神经痛的药物及其用途
RU2741079C1 (ru) * 2020-04-06 2021-01-22 Общество С Ограниченной Ответственностью "Технологии Дкв" Пищевая добавка «пребио дкв»

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1118725A (ja) * 1997-06-23 1999-01-26 Soc Prod Nestle Sa 糖尿病患者用栄養組成物
JP2006052191A (ja) * 2004-08-16 2006-02-23 Taiyo Kagaku Co Ltd 糖尿病予防、改善、または治療用組成物
JP2008500955A (ja) * 2003-10-27 2008-01-17 イノディア インコーポレイテッド 糖尿病の治療に使用するための方法及び組成物
US20090214511A1 (en) * 2008-02-21 2009-08-27 Trung Hong Tran Digestible compositions of inulin for managing blood glucose levels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082842A (en) * 1975-02-21 1978-04-04 Armando Nahle Medicant composition for the treatment of diabetes
US5859037A (en) 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
US20030130205A1 (en) 2000-04-12 2003-07-10 Christian Samuel T. Novel pharmaceutical anti-infective agents containing carbohydrate moieties and methods of their preparation and use
US6689385B2 (en) * 2000-11-03 2004-02-10 Chronorx Llc Formulations for the treatment of insulin resistance and type 2 diabetes mellitus
WO2004070009A2 (en) * 2003-01-31 2004-08-19 Targesome Inc. Targeted multivalent macromolecules
CN1861173A (zh) * 2005-05-13 2006-11-15 王锦 糖尿病人营养治疗药品膳食纤维素粉产品
EP1893041A4 (en) 2005-06-17 2009-05-13 Henry H Ottens Mfg Company Inc FIBER-REINFORCED CEREALS, CEREAL BARS AND FOODS AND METHODS OF MAKING
EP1832179B1 (en) * 2005-12-20 2018-11-07 N.V. Nutricia Carbohydrate composition and flat glucose response
ATE529093T1 (de) * 2007-05-10 2011-11-15 Oreal Kosmetische zusammensetzung mit einem inulinderivat in form einer volumsexpandierten emulsion
GB0907019D0 (en) * 2009-04-24 2009-06-03 Oxford Nutrascience Ltd Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
WO2010124387A1 (en) 2009-05-01 2010-11-04 Micropharma Limited Bacterial compositions for prophylaxis and treatment of degenerative disease
US9241952B2 (en) * 2010-05-24 2016-01-26 Ozstar Therapeutics Pty Ltd Method of treating type II diabetes, hyperglycemia or hypoglycemia by administering a synergistic combination of a sulphonylurea and inulin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1118725A (ja) * 1997-06-23 1999-01-26 Soc Prod Nestle Sa 糖尿病患者用栄養組成物
JP2008500955A (ja) * 2003-10-27 2008-01-17 イノディア インコーポレイテッド 糖尿病の治療に使用するための方法及び組成物
JP2006052191A (ja) * 2004-08-16 2006-02-23 Taiyo Kagaku Co Ltd 糖尿病予防、改善、または治療用組成物
US20090214511A1 (en) * 2008-02-21 2009-08-27 Trung Hong Tran Digestible compositions of inulin for managing blood glucose levels

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ACTIVE FOOD SCIENTIFIC MONITOR, AN ORAFTI NEWSLETTER, NO.12, SPRING 2005, JPN7016002456, ISSN: 0003384693 *
BRIT. J. NUTRIT., 2005, VOL. 93, NO. S1, PP. S157-S161, JPN6016032330, ISSN: 0003384692 *
J. BIOSCI., VOL.27, NO.7, DEC, 2002, PP.703-714, JPN6016032333, ISSN: 0003384694 *

Also Published As

Publication number Publication date
CA2861661A1 (en) 2013-05-30
EP2782586A4 (en) 2015-07-01
CA2861661C (en) 2021-03-16
JP2017226672A (ja) 2017-12-28
CN104244958B (zh) 2017-11-17
KR20150002575A (ko) 2015-01-07
WO2013075172A1 (en) 2013-05-30
RU2642633C2 (ru) 2018-01-25
JP6609287B2 (ja) 2019-11-20
BR112014012401A2 (pt) 2017-06-13
IN2014KN01304A (en) 2015-10-16
EP2782586A1 (en) 2014-10-01
RU2014125249A (ru) 2015-12-27
CN104244958A (zh) 2014-12-24
AU2012343332A1 (en) 2014-07-17
AU2012343332B2 (en) 2017-03-16
US20140303118A1 (en) 2014-10-09
US9737559B2 (en) 2017-08-22
KR102104384B1 (ko) 2020-04-27

Similar Documents

Publication Publication Date Title
CN102150836B (zh) 氨糖多肽软胶囊
US20030232067A1 (en) Use of pullulan as a slowly digested carbohydrate
AU2001296196B2 (en) New composition and method for the treatment of dysglucaemia
JP6609287B2 (ja) 改良された相乗作用を示す抗糖尿病、抗高血糖症又は抗副作用のための医薬組成物及び製剤
EP2875809B1 (en) Product based on an association of glucomannan and inositol
EP2635130B1 (en) Composition of purified soluble mannans for dietary supplements and methods of use thereof
US20190230969A1 (en) Composition of purified soluble mannans for dietary supplements and methods of use thereof
JP5897796B2 (ja) 血糖低下剤及びそれを添加してなる糖尿病の予防又は症状改善のための飲食品
JP7398207B2 (ja) Ｔｏｘｉｃ ＡＧＥｓ生成抑制剤
EP2575826B1 (en) Anti-diabetic compositions
JP7702410B2 (ja) フルカロリーの遅消化性炭水化物組成物
AU2023407188B2 (en) Composition for preventing and/or treating metabolic disorders and method of its preparation
TW201429486A (zh) 調節血糖中草藥組成物及其製備方法
CN108451935A (zh) 一种含有米格列奈钙的固体药物组合物
JP7329768B2 (ja) 糖尿病予防治療剤、血糖値上昇抑制剤、血糖値スパイク抑制剤及びグルコース取り込み阻害剤
KR100500158B1 (ko) 레반을 이용한 비만 개선 식이 조성물
TW202612720A (zh) 毛豆胜肽在降血糖上的用途
JP2023026265A (ja) 肥満，高血糖モデルの作製方法及び予防及び治療の評価方法
EP4203713A1 (en) New system with emerging properties for use in the treatment of metabolic syndrome
CN121969248A (zh) 用于改善肌肉功能的组合物及食品组合物
Young et al. Pharmacologic Management of Type 2 Diabetes Mellitus: Part 2
CN114794487A (zh) 一种治疗糖尿病的方法
HK1210016B (en) Product based on an association of glucomannan and inositol

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161130

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170307